BURNING ROCK BIOTECH LTD.

History

YearDetail
2014 Burning Rock Biotech Ltd., a biotechnology company that focuses on the application of next-generation sequencing (NGS) technology in precision oncology, was founded in 2014.
2020 Burning Rock Biotech and CStone Pharmaceuticals partnered to co-develop and commercialize companion diagnostics (CDx) for pralsetinib, an investigational treatment developed by CStone’s partner Blueprint Medicines.
AI Sentiment